ClotCare: Blood Clots, Stroke, Heart Attack
Saturday, June 24, 2017
Home   |   DVT/PE   |   Blood Clots   |   Coumadin/Warfarin   |   New Patients   |   Self Testing   |   Email List   |   Donate

Pick a Topic:

Find info on a:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.

ClotCare is a member of the Coalition to Prevent Deep Vein Thrombosis (DVT Coalition)  ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

Carotid Endarterectomy still the "gold standard" for revascularization in symptomatic patients.

Susan C. Fagan, Pharm.D., BCPS, FCCP
December, 2006

Study: Mas J-L, Chatellier G, Beyssen B, et al. Endarterectomy versus Stenting in Patients with Severe Carotid Stenosis. N Engl J Med 2006;355:1660-1671.

Editorial: Furlan AJ. Carotid artery stenting - case open or closed? N Engl J Med 2006;355:1726-1729.

Carotid endarterectomy is a highly effective surgical procedure for reducing the risk of recurrent thromboembolic events in patients with symptomatic (ischemic symptoms emanating from brain on the side of the stenosis) carotid artery stenosis of 60-99%. It carries with it, however, a significant risk of perioperative stroke and death (up to 6% is acceptable to make the procedure still worth the risk in symptomatic patients). In addition, the cranial nerve injury due to the invasive procedure can be irreversible. There has been a move to develop less invasive, endovascular procedures (stenting) to decrease the morbidity of the procedure. In the previously published SAPPHIRE trial, stenting was as effective as endarterectomy but appeared to be safer in a primarily asymptomatic population, where the perioperative risk is lower.1 In this trial, EVA-3S, despite the use of protective devices to prevent perioperative embolization (92% of patients) and dual antiplatelet therapy for 3 days before and 30 days after (82%) in most patients, the study was stopped early for safety and futility. In the stented group, the 30 day incidence of stroke or death was 9.6%, compared to 3.9% with endarterectomy. This was highly significant. Most of the events in the stented group occurred on the day of the procedure.

It is clear that the gold standard for revascularization of symptomatic carotid stenosis remains carotid endarterectomy. Only in patients where surgery is not an option should stenting be considered.

1. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2006;355:1660-1671.

Ask a question about blood clots or anticoagulant medications Have questions? Ask ClotCare. Send questions by email to webmaster@clotcare.org.

ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.

Blood Clot Activities Calendar

New Postings:

Research Company Seeks Patients who Have Had a Leg Blood Clot (deep vein thrombosis or DVT)

Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2014 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-495-4335
Send comments to webmaster@clotcare.org.
Saturday, June 24, 2017